Ghildyal Reena, Jans David A, Bardin Philip G, Mills John
Faculty of Applied Science, University of Canberra, Canberra, Australia.
Infect Disord Drug Targets. 2012 Apr;12(2):103-9. doi: 10.2174/187152612800100125.
Respiratory syncytial virus (RSV) is the major respiratory pathogen of infants and children worldwide, with no effective treatment or vaccine available. Steady progress has been made in understanding the respiratory syncytial virus lifecycle and the consequences of infection, but some areas of RSV still remain poorly understood. Although many of the interactions between virus proteins that are required for efficient RSV assembly have been elucidated, many questions still remain regarding viral assembly, as well as the mechanisms of RSV budding. This review will summarise the current understanding of RSV assembly, including the various interactions between virus proteins and the involvement of cellular factors with a view to identifying possible attenuation and/or drug targets within the assembly pathway.
呼吸道合胞病毒(RSV)是全球婴幼儿主要的呼吸道病原体,目前尚无有效的治疗方法或疫苗。在了解呼吸道合胞病毒生命周期及感染后果方面已取得稳步进展,但RSV的一些领域仍了解不足。尽管高效RSV组装所需的病毒蛋白之间的许多相互作用已得到阐明,但关于病毒组装以及RSV出芽机制仍存在许多问题。本综述将总结目前对RSV组装的理解,包括病毒蛋白之间的各种相互作用以及细胞因子的参与情况,以期确定组装途径中可能的减毒和/或药物靶点。